Aggressive maxillofacial disassembly in skull base surgery.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 16890088.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To review our favorable experience with maxillofacial disassembly for exposure and resection of tumors of the skull base. This is a retrospective review of 31 patients from 1997 to 2005 treated by maxillofacial disassembly and includes 22 patients with midface disassembly and 9 patients with mandible with or without midface disassembly. Follow-up ranges from 2 weeks to 7 years: 23 (74.2%) of 31 patients are alive and disease free; 3 patients are alive with disease; 3 patients have died of distant metastasis. There were 14 complications in 12 (38.7%) patients; 13 of 14 complications were minor. One major complication (cardiovascular accident) resulted in the single postoperative mortality in this series. Our technique of maxillofacial disassembly allows for tailored exposure of all regions of the anterolateral skull base with acceptable perioperative morbidity in appropriately selected patients. C-4.
Medical subject headings
- Carcinoma, Squamous Cell
- Esthesioneuroblastoma, Olfactory
- Facial Bones
- Mandible
- Meningioma
- Osteotomy
- Skull Base
- Skull Base Neoplasms